Results 311 to 320 of about 138,544 (375)

Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data

open access: yesFundamental &Clinical Pharmacology, Volume 39, Issue 4, August 2025.
ABSTRACT Background and Objectives Despite limited paediatric approvals, the use of proton pump inhibitors (PPIs) among children has increased in recent years, and concerns have arisen about their safety, including the risk of allergies. To provide additional evidence on the paediatric safety of PPIs, we performed a study on suspected adverse drug ...
Greta Santi Laurini   +3 more
wiley   +1 more source

Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction. [PDF]

open access: yesClin Transl Allergy
Rhyou HI   +17 more
europepmc   +1 more source

Administration of nivolumab plus ipilimumab: Infusion of the fixed‐ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)

open access: yesCancer, Volume 131, Issue 14, 15 July 2025.
Abstract Background Immune checkpoint inhibitors can be coadministered as a fixed‐ratio combination (FRC) or administered as sequential infusions (ASI). Two randomized, open‐label trials compared nivolumab + ipilimumab as a FRC versus ASI in patients with melanoma or renal cell carcinoma.
Alexander M. Menzies   +19 more
wiley   +1 more source

Cost‐Effectiveness of Ferritin Screening Thresholds for Iron Deficiency in Reproductive‐Age Women

open access: yesAmerican Journal of Hematology, Volume 100, Issue 7, Page 1132-1140, July 2025.
ABSTRACT Iron deficiency (ID) is a top five leading cause of disability‐adjusted life‐years in women of reproductive age around the world. Despite its enormous health burden, no screening guidelines exist for the detection and treatment of ID in women of reproductive age.
Daniel Wang   +7 more
wiley   +1 more source

Sudden death after one wasp sting [PDF]

open access: yes, 1990
Eisenmenger, Wolfgang   +3 more
core  

Omega-5-Gliadin Allergy and Cofactors Leading to Anaphylaxis: A Case Report. [PDF]

open access: yesCureus
Le Bon Chami B   +4 more
europepmc   +1 more source

Rare Presentation of Adult‐Onset Still's Disease Complicated by Acute Severe Hepatitis Refractory to Medical Treatment: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 7, July 2025.
ABSTRACT Managing adult‐onset Still's disease complicated by severe hepatitis requires vigilant monitoring and adaptable therapeutic strategies. Standard treatments such as tocilizumab and rituximab can cause adverse reactions or lose efficacy. The interplay of systemic inflammation and liver involvement highlights the need for ongoing research to find
Majed Ali   +3 more
wiley   +1 more source

Omalizumab pretreatment in a case of pediatric carboplatin desensitization. [PDF]

open access: yesPediatr Allergy Immunol
Brozyna JR   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy